NHS-IL12 M9241
Showing 1 - 25 of 9,065
Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy
Recruiting
- Urothelial Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute
Recruiting
- Cancer
- +3 more
- Bintrafusp Alfa
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 2, 2022
Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic
Terminated
- Histologically or Cytologically Confirmed Pancreatic Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 19, 2022
Small Bowel Cancers, Colorectal Cancers Trial run by the NCI (CV301, MSB0011359C, N-803)
Recruiting
- Small Bowel Cancers
- Colorectal Cancers
- CV301
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)
Active, not recruiting
- Cervical Cancer
- +4 more
- PDS0101
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Epithelial Tumors, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor Trial run by the NCI (NHS-IL-12)
Completed
- Epithelial Neoplasms, Malignant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 15, 2021
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- Cancer Of Prostate
- M9241
- Stereotactic Body Radiation Therapy (SBRT)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)
Not yet recruiting
- HIV Infections
- sD-NP-GT8 DNA
- +4 more
-
Birmingham, Alabama
- +5 more
Mar 10, 2023
Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)
Recruiting
- Cancer Of Prostate
- Prostate Neoplasms
- ADT
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)
Completed
- Intracerebral Haemorrhage
- IL-1Ra Kineret®
- IL-1Ra Placebo
-
Manchester, North West, United KingdomSalford Royal NHS Foundation Trust
Oct 4, 2021
Acute Myeloid Leukemia Trial in Toronto (IL-12)
Recruiting
- Acute Myeloid Leukemia
- IL-12
-
Toronto, Ontario, CanadaPrincess Margaret Centre Centre
Apr 16, 2021
Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in
Active, not recruiting
- Recurrent Glioblastoma Multiforme
- +2 more
- M032 (NSC 733972)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 26, 2022
Breast Cancer Trial in United Kingdom (Hydrogen Peroxide)
Recruiting
- Breast Cancer
- Hydrogen Peroxide
-
Lucknow, Uttar Pradesh, India
- +7 more
Sep 21, 2022
Investigate Adaptation and Evolution of Ovarian High-grade
Recruiting
- Ovarian Cancer
- +6 more
-
Bristol, United Kingdom
- +10 more
Sep 8, 2022
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Glioblastoma, Brain Tumor, Cannabis Trial in United Kingdom (Sativex, Temozolomide, Sativex-matched )
Not yet recruiting
- Glioblastoma
- +3 more
- Sativex
- +2 more
-
Belfast, United Kingdom
- +14 more
Nov 29, 2022
Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)
Active, not recruiting
- Non Hodgkin Lymphoma
- R-CHOP + acalabrutinib
-
Southampton, Hampshire, United Kingdom
- +6 more
Oct 26, 2022